Zagazig university
Zagazig, Egypt
NCT Number: NCT04442906
The aim of this study is to evaluate analgesic effects Bupivacaine, Bupivacaine plus Dexmedetomidine and Bupivacaine plus Fentanyl in relieving pain after knee arthroscopic surgery.
Looking for future studies?
Notify Me21 year–45 year
All sexes
Interventional
Not applicable
Zagazig, Egypt
Forty-five patients ASA I - II aged 21-45 years for elective knee arthroscopy were divided into 3 groups: Group B, BD and BF. Group B received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml saline. Group BD received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml dexmedetomidine (100 ug).
Group BF received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 fentanyl (50 ug). The time of first request of analgesia and analgesic effect by VAS during the first 24 hr. postoperatively are recorded.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group BD received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml dexmedetomidine (100 ug).
Other names: precedex
Group BF received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 fentanyl (50 ug)
Group B received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml saline.
Other names: marcaine
Time frame: For 24 hours postoperative
start from intra-articular injection of the drug to the time of first request of analgesia
Time frame: within 24 hours postoperative
total consumption of rescue analgesia (pethidine) postoperative
Time frame: Within 24 hours postoperative
The number of participants with bradycardia less than 50 beat per minute, itching and hypotension if mean arterial blood pressure less than 20% of basal )
Time frame: within 24 hours postoperative
Patient satisfaction by five point Likert-Like verbal rating scale by asking the patient how they evaluate the experience with the analgesic management after the the surgery? (5-very satisfied, 4-satisfied, 3-neutral, 2-dissatisfied, 1-very dissatisfied)
Time frame: measured immediately preoperative 0 minute ( admission receiving area)
measured by VAS on 0-10 cm scale (0- no pain and 10-the worst pain)
Time frame: at 30 minutes postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 1 hour postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 2 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 4 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 6 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 8 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 12 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 18 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 24 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: measured immediately preoperative 0 minute ( admission receiving area)
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 30 minutes postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 1 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 2 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 4 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 6 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 8 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 12 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 18 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Time frame: at 24 hours postoperative
measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)
Zagazig University
Other Gov
Comparative Study Between Dexmedetomidine and Fentanyl as an Adjuvant to Intra-articular Bupivacaine for Postoperative Analgesia After Knee Arthroscopy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05999734
Agnosia, Analgesia
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT02471898
Agnosia, Analgesia
Pasadena, California, United States
View Trial DetailsNCT06675916
Agnosia, Analgesia
Villeurbanne, France
View Trial DetailsNCT05250492
Agnosia, Analgesia
Lanester, France
View Trial Details